Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BY-NC-NDBMC endocrine disorders

Hair cortisol as a complementary marker of chronic glucocorticoid exposure in mild autonomous cortisol secretion.

  1. 1Department of Endocrinology and Metabolism, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
  2. 2Department of Medical Biochemistry, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
  3. 3Department of Endocrinology and Metabolism, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey. [email protected].

Abstract

Background

Mild autonomous cortisol secretion is a subtle yet clinically relevant form of cortisol excess linked to increased cardiometabolic risk. Conventional biochemical tests capture short-term hypothalamic-pituitary-adrenal axis activity and may not reflect cumulative exposure. Hair cortisol concentration has been proposed as a long-term biomarker, but evidence in mild autonomous cortisol secretion is limited.Objective

To compare hair cortisol concentration between patients with mild autonomous cortisol secretion and healthy controls, assess diagnostic performance, and examine associations with hormonal and metabolic parameters.Methods

In this cross-sectional study, 73 patients with mild autonomous cortisol secretion and 60 rigorously screened controls were included. Mild autonomous cortisol secretion was defined according to European Society of Endocrinology guidelines. Hair cortisol concentration was measured from the proximal 3-cm hair segment. Assessments included the 1-mg overnight dexamethasone suppression test, 2-day 2 mg dexamethasone suppression test, 24-hour urinary free cortisol, and late-night salivary cortisol. Correlation and receiver operating characteristic analyses were performed.Results

Hair cortisol concentration was significantly higher in patients with mild autonomous cortisol secretion than in controls (median 3.6 vs. 1.75 ng/g; p < 0.01). In patients with mild autonomous cortisol secretion, hair cortisol concentration correlated with waist circumference (ρ = 0.27; p = 0.02) and late-night salivary cortisol (ρ = 0.25; p = 0.03), but not with dexamethasone suppression test-based measures or urinary cortisol. Receiver operating characteristic analysis showed modest discrimination (AUC = 0.60, 95% CI 0.51-0.70, p = 0.025); the 2.7-ng/g cut-off yielded limited sensitivity and specificity. In multivariable logistic regression adjusted for age, sex, and body mass index, hair cortisol concentration was not independently associated with mild autonomous cortisol secretion.Conclusions

Hair cortisol concentrations were higher in patients with mild autonomous cortisol secretion than in healthy controls, suggesting that hair cortisol concentration may capture some aspects of chronic glucocorticoid exposure in this population. However, its diagnostic performance was modest, and hair cortisol concentration was not independently associated with mild autonomous cortisol secretion after adjustment for age, sex, and body mass index. Therefore, hair cortisol concentration should be regarded as a complementary rather than a standalone biomarker, and further prospective studies are needed to clarify its clinical utility.

Related

  1. Prevalence of Mild Autonomous Cortisol Secretion Among Patients With Adrenal Incidentaloma and Its Association With Metabolic Abnormalities: A Hospital-Based, Analytical, Cross-Sectional Study
    Wardah Ikram
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Multi-omics profiling reveals molecular features of visceral adiposity in autonomous cortisol secretion
    Hiroshi Nakao, Maki Yokomoto-Umakoshi, Masamichi Fujita +15
    iSciencePeer-reviewedCC BY 4.0Full textEpidemiology & public healthCell PressCrossrefEurope PMC
  3. Retinal Microvascular and Peripapillary Profiles in Mild Autonomous Cortisol Secretion Versus Nonfunctioning Adrenal Adenomas
    Selin Şimşek Alkan, Aslı Vural, Vildan Gürses Beşli +7
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossrefEurope PMC
  4. Mild Autonomous Cortisol Secretion Is Associated with Computed Tomography-Derived Hepatic Steatosis in Patients with Adrenal Incidentaloma.
    Samet Alkan, Mustafa Farasat, Can Akcura +5
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  5. Maternal PFOS exposure impairs β-cell insulin secretion and glucose tolerance in rats
    Alissa Hofmann, Pankaj Yadav, Ruolin Song +3
    Toxicological SciencesPeer-reviewedPublisher termsFull textSurgery & anaesthesiaPMC
BibTeX
@article{yilmaz2026hair,
  title = {{Hair cortisol as a complementary marker of chronic glucocorticoid exposure in mild autonomous cortisol secretion.}},
  author = {Merve Korkmaz Yilmaz and Semih Tek and Aslihan Pekmezci and Mutlu Niyazoglu and Esra Hatipoglu},
  journal = {BMC endocrine disorders},
  year = {2026},
  month = sep,
  doi = {10.1186/s12902-026-02607-1},
  url = {https://europepmc.org/article/MED/42897569},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Hair cortisol as a complementary marker of chronic glucocorticoid exposure in mild autonomous cortisol secretion.
AU  - Merve Korkmaz Yilmaz
AU  - Semih Tek
AU  - Aslihan Pekmezci
AU  - Mutlu Niyazoglu
AU  - Esra Hatipoglu
PY  - 2026
DA  - 2026/09/01
JO  - BMC endocrine disorders
DO  - 10.1186/s12902-026-02607-1
UR  - https://europepmc.org/article/MED/42897569
AB  - Background  Mild autonomous cortisol secretion is a subtle yet clinically relevant form of cortisol excess linked to increased cardiometabolic risk. Conventional biochemical tests capture short-term hypothalamic-pituitary-adrenal axis activity and may not reflect cumulative exposure. Hair cortisol concentration has been proposed as a long-term biomarker, but evidence in mild autonomous cortisol secretion is limited.Objective  To compare hair cortisol concentration between patients with mild autonomous cortisol secretion and healthy controls, assess diagnostic performance, and examine associations with hormonal and metabolic parameters.Methods  In this cross-sectional study, 73 patients with mild autonomous cortisol secretion and 60 rigorously screened controls were included. Mild autonomous cortisol secretion was defined according to European Society of Endocrinology guidelines. Hair cortisol concentration was measured from the proximal 3-cm hair segment. Assessments included the 1-mg overnight dexamethasone suppression test, 2-day 2 mg dexamethasone suppression test, 24-hour urinary free cortisol, and late-night salivary cortisol. Correlation and receiver operating characteristic analyses were performed.Results  Hair cortisol concentration was significantly higher in patients with mild autonomous cortisol secretion than in controls (median 3.6 vs. 1.75 ng/g; p < 0.01). In patients with mild autonomous cortisol secretion, hair cortisol concentration correlated with waist circumference (ρ = 0.27; p = 0.02) and late-night salivary cortisol (ρ = 0.25; p = 0.03), but not with dexamethasone suppression test-based measures or urinary cortisol. Receiver operating characteristic analysis showed modest discrimination (AUC = 0.60, 95% CI 0.51-0.70, p = 0.025); the 2.7-ng/g cut-off yielded limited sensitivity and specificity. In multivariable logistic regression adjusted for age, sex, and body mass index, hair cortisol concentration was not independently associated with mild autonomous cortisol secretion.Conclusions  Hair cortisol concentrations were higher in patients with mild autonomous cortisol secretion than in healthy controls, suggesting that hair cortisol concentration may capture some aspects of chronic glucocorticoid exposure in this population. However, its diagnostic performance was modest, and hair cortisol concentration was not independently associated with mild autonomous cortisol secretion after adjustment for age, sex, and body mass index. Therefore, hair cortisol concentration should be regarded as a complementary rather than a standalone biomarker, and further prospective studies are needed to clarify its clinical utility.
SN  - 1472-6823
ER  -